BIM
CRL icon

BlackRock Investment Management’s Charles River Laboratories CRL Stock Holding History

BlackRock Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$12.3M Buy
161,568
+27,059
+20% +$2.06M 0.01% 980
2016
Q3 		$11.2M Buy
134,509
+458
+0.3% +$38.4K 0.01% 931
2016
Q2 		$11.1M Buy
134,051
+4,628
+4% +$381K 0.01% 893
2016
Q1 		$9.83M Sell
129,423
-29,397
-19% -$2.18M 0.01% 937
2015
Q4 		$12.8M Sell
158,820
-39,509
-20% -$2.85M 0.02% 804
2015
Q3 		$12.6M Sell
198,329
-2,222
-1% -$160K 0.02% 787
2015
Q2 		$14.1M Buy
200,551
+10,811
+6% +$800K 0.02% 764
2015
Q1 		$15M Buy
189,740
+5,763
+3% +$425K 0.02% 712
2014
Q4 		$11.7M Buy
183,977
+2,814
+2% +$176K 0.02% 840
2014
Q3 		$10.8M Sell
181,163
-1,609
-0.9% -$92.1K 0.02% 875
2014
Q2 		$9.78M Buy
182,772
+47,733
+35% +$2.62M 0.01% 981
2014
Q1 		$8.15M Sell
135,039
-2,713
-2% -$158K 0.01% 1057
2013
Q4 		$7.31M Sell
137,752
-3,493
-2% -$175K 0.01% 1098
2013
Q3 		$6.53M Buy
141,245
+12,785
+10% +$587K 0.01% 1113
2013
Q2 		$5.27M Buy
+128,460
New +$5.5M 0.01% 1181

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BlackRock Investment Management's CRL Position: Q4 2016 in Review

BlackRock Investment Management increased its Charles River Laboratories (CRL) stake by 20% in Q4 2016, buying an estimated $2.06M and bringing the position to 161,568 shares worth $12.3M. The position accounts for 0.01% of the portfolio, ranked #980.

BlackRock Investment Management first reported a position in CRL in Q2 2013 and has held it in 15 quarters since. The position peaked at $15M in Q1 2015. 297 funds tracked by Wall St. Rank hold CRL as of Q4 2016.

  • BlackRock Investment Management held 161,568 shares of Charles River Laboratories worth $12.3M as of Q4 2016.
  • BlackRock Investment Management bought 27,059 Charles River Laboratories shares in Q4 2016, an estimated $2.06M.
  • Charles River Laboratories made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #980 holding.
  • BlackRock Investment Management first reported a position in Charles River Laboratories in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Charles River Laboratories position peaked at $15M in Q1 2015.
  • 297 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.